AU2003223526A1 - A gene abnormally expressed in autoimmune diseases and malignancies - Google Patents

A gene abnormally expressed in autoimmune diseases and malignancies

Info

Publication number: AU2003223526A1
Authority: AU; Australia
Prior art keywords: malignancies; autoimmune diseases; abnormally expressed; gene; gene abnormally
Prior art date: 2002-04-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2003223526A

Other languages

English (en)

Inventor

Leonard N. Chen

Dora Harrison Connelly

Robbert H. J. Crusio

Carolyn L. Greene

Maria C. Grekova

John R. Richert

Colin G. Rose

Bi-Ying Xu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

GEORGTOWN UNIVERSITY

Original Assignee

GEORGTOWN UNIVERSITY

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-24

Filing date

2003-04-10

Publication date

2003-11-10

2003-04-10 Application filed by GEORGTOWN UNIVERSITY filed Critical GEORGTOWN UNIVERSITY

2003-11-10 Publication of AU2003223526A1 publication Critical patent/AU2003223526A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/285—Demyelinating diseases; Multipel sclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Analytical Chemistry (AREA)
Biotechnology (AREA)
Pathology (AREA)
Physics & Mathematics (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Microbiology (AREA)
Cell Biology (AREA)
General Physics & Mathematics (AREA)
Biophysics (AREA)
Food Science & Technology (AREA)
Wood Science & Technology (AREA)
Hospice & Palliative Care (AREA)
Oncology (AREA)
Rehabilitation Therapy (AREA)
Rheumatology (AREA)
Bioinformatics & Cheminformatics (AREA)
General Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AU2003223526A 2002-04-24 2003-04-10 A gene abnormally expressed in autoimmune diseases and malignancies Abandoned AU2003223526A1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US37482002P	2002-04-24	2002-04-24
US60/374,820		2002-04-24
PCT/US2003/010902 WO2003091269A1 (fr)	2002-04-24	2003-04-10	Gene anormalement exprime dans les maladies auto-immunes et les malignites

Publications (1)

Publication Number	Publication Date
AU2003223526A1 true AU2003223526A1 (en)	2003-11-10

Family

ID=29270553

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2003223526A Abandoned AU2003223526A1 (en)	2002-04-24	2003-04-10	A gene abnormally expressed in autoimmune diseases and malignancies

Country Status (2)

Country	Link
AU (1)	AU2003223526A1 (fr)
WO (1)	WO2003091269A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2007071437A2 (fr) *	2005-12-22	2007-06-28	Ares Trading S.A.	Compositions et méthodes pour traiter des troubles inflammatoires

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6190857B1 (en) *	1997-03-24	2001-02-20	Urocor, Inc.	Diagnosis of disease state using MRNA profiles in peripheral leukocytes

2003
- 2003-04-10 WO PCT/US2003/010902 patent/WO2003091269A1/fr not_active Ceased
- 2003-04-10 AU AU2003223526A patent/AU2003223526A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003091269A1 (fr)	2003-11-06

Publication	Publication Date	Title
AU2003300017A1 (en)	2004-07-29	Microprocessor and microprocessor operation
AU2002950303A0 (en)	2002-09-12	Improvements in assembly and disassembly
AU2003210973A1 (en)	2003-09-04	Managed object replication and delivery
AU2003287519A1 (en)	2004-06-18	Microprocessor including a first level cache and a second level cache having different cache line sizes
AU2003282212A1 (en)	2004-05-04	Facilitating and authenticating transactions
AU2003223385A1 (en)	2003-10-20	Automated bioculture and bioculture experiments system
AU2003302093A1 (en)	2004-06-15	Product and service risk management clearinghouse
AU2002951892A0 (en)	2002-10-24	Mining process and design
AU2003302997A1 (en)	2004-07-09	Product promotion and sales in computer games
AUPS281802A0 (en)	2002-06-27	A storage process and system
AU2003258017A1 (en)	2004-02-23	Shoe manufacturing and recycling system
AU2003208495A1 (en)	2003-09-22	Rf and baseband subsystems interface
AU2003295418A1 (en)	2004-06-03	Catalyst having metal in reduced quantity and reduced cluster size
AU2003220387A1 (en)	2003-10-08	Gene amplification in cancer
AU2003230272A1 (en)	2003-12-02	Multiple insert delivery systems and methods
AU2003253629A1 (en)	2003-12-22	Large deletions in human brca1 gene and use thereof
AU2003290573A1 (en)	2004-06-03	Cross-linked oligomeric compounds and their use in gene modulation
AU2003206945A1 (en)	2003-09-09	Use of proteinase inhibitors in the treatment of autoimmune diseases
AU2003227404A1 (en)	2003-11-03	Discharge light and back light
AU2003223526A1 (en)	2003-11-10	A gene abnormally expressed in autoimmune diseases and malignancies
AUPS271902A0 (en)	2002-06-20	Gene expression and multiple sclerosis
AU2003239589A1 (en)	2003-12-12	Eta-1 gene and methods for use
AU2003302173A1 (en)	2004-07-14	Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003255726A1 (en)	2004-02-16	Releasable fastener and receptacle
GB0210538D0 (en)	2002-06-19	Lipids and gene delivery

Legal Events

Date	Code	Title	Description
2005-01-13	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase